Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

Grupp SA, Maude SL, Rives S, Hiramatsu H, Baruchel A, Bader P, Bittencourt H, Buechner J, Laetsch TW, De Moerloose B, Qayed M, Stefanski HE, Davis KL, Driscoll TA, Nemecek E, Peters C, Yanik G, Balduzzi A, Boissel N, Khaw SL, Krueger J, Levine JE, Myers GD, Tiwari R, O'Donovan D, Awasthi R, Ramos R, Willert J, Pulsipher MA

Open source

DOI: 10.1200/jco-25-01471
Published: 2026 Nov
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-01471,
  title = {Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.},
  author = {Grupp SA and Maude SL and Rives S and Hiramatsu H and Baruchel A and Bader P and Bittencourt H and Buechner J and Laetsch TW and De Moerloose B and Qayed M and Stefanski HE and Davis KL and Driscoll TA and Nemecek E and Peters C and Yanik G and Balduzzi A and Boissel N and Khaw SL and Krueger J and Levine JE and Myers GD and Tiwari R and O'Donovan D and Awasthi R and Ramos R and Willert J and Pulsipher MA},
  year = {2026},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-25-01471},
  url = {https://doi.org/10.1200/jco-25-01471}
}

RIS

TY  - JOUR
TI  - Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.
AU  - Grupp SA
AU  - Maude SL
AU  - Rives S
AU  - Hiramatsu H
AU  - Baruchel A
AU  - Bader P
AU  - Bittencourt H
AU  - Buechner J
AU  - Laetsch TW
AU  - De Moerloose B
AU  - Qayed M
AU  - Stefanski HE
AU  - Davis KL
AU  - Driscoll TA
AU  - Nemecek E
AU  - Peters C
AU  - Yanik G
AU  - Balduzzi A
AU  - Boissel N
AU  - Khaw SL
AU  - Krueger J
AU  - Levine JE
AU  - Myers GD
AU  - Tiwari R
AU  - O'Donovan D
AU  - Awasthi R
AU  - Ramos R
AU  - Willert J
AU  - Pulsipher MA
PY  - 2026
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-25-01471
UR  - https://doi.org/10.1200/jco-25-01471
ER  -

APA

SA, G., SL, M., S, R., H, H., A, B., P, B., H, B., J, B., TW, L., B, D. M., M, Q., HE, S., KL, D., TA, D., E, N., C, P., G, Y., A, B., N, B., SL, K., J, K., JE, L., GD, M., R, T., D, O., R, A., R, R., J, W., & MA, P. (2026). Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-25-01471

Source records

pubmed · retrieved 2026-11-11T01:14:35.319Z